國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cell and gene therapies

Abutalib, Syed A.

Cell and gene therapies

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cell and gene therapiesedited by Miguel-Angel Perales, Syed A. Abutalib, Catherine Bollard.
其他作者:	Perales, Miguel-Angel.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	vi, 288 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Cellular therapy.
電子資源:	https://doi.org/10.1007/978-3-319-54368-0
ISBN:	9783319543680$q(electronic bk.)

Cell and gene therapies
Cell and gene therapies[electronic resource] /edited by Miguel-Angel Perales, Syed A. Abutalib, Catherine Bollard. - Cham :Springer International Publishing :2019. - vi, 288 p. :ill., digital ;24 cm. - Advances and controversies in hematopoietic transplantation and cell therapy,2569-1376. - Advances and controversies in hematopoietic transplantation and cell therapy..

Historical perspective and current focus -- Part I: Genetically modified T cells (Chimeric antigen receptors and T cell receptors): Chimeric antigen receptor-T cells: Antigen selection, CAR development and future prospects -- Chimeric antigen receptor-T cells for leukemias in children: Methods, data and challenges -- Chimeric antigen receptor-T cells for leukemias in adults- Methods, data and challenges -- Chimeric antigen receptor-T cells for lymphomas: Methods, data and challenges -- T-cell receptors-gene modified T-cells for cancer -- Methods, data and challenges. -- Part II: Beyond chimeric antigen receptor and T-cell receptors - Data, Consensus & Challenges: Cytotoxic T cells for infections: From donor-specific to "off the shelf" -- Donor lymphocyte infusion in different transplant settings: When and how?- T-regulatory cells: Broadening applicability -- Tumor infiltrating lymphocytes: Current concepts and practices -- Part III: Beyond T-cells: Natural killer cells: What have we learned?- Dendritic cells in hematopoietic cell transplantation -- Mesenchymal stem cells: From bench to bedside and back -- Cell Therapies: Regulatory concerns and data collection -- Part IV: Gene Therapy: Gene therapy for hematologic malignancies and in transplant setting -- Gene therapy for nonmalignant disorders -- Future prospects of cell and gene therapies.

In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with information that is relevant to clinical practice and ongoing research. Each chapter focuses on a particular topic, and the concise text is supported by numerous working tables, algorithms, and figures. Whenever appropriate, guidance is provided regarding the availability of potentially high-impact clinical trials. The rapid evolution of cell and gene therapies is giving rise to numerous controversies that need to be carefully addressed. In meeting this challenge, this book will appeal to all residents, fellows, and faculty members responsible for the care of hematopoietic cell transplant patients. It will also offer a robust, engaging tool to aid vital activities in the daily work of every hematology and oncology trainee.

ISBN: 9783319543680$q(electronic bk.)

Standard No.: 10.1007/978-3-319-54368-0doiSubjects--Topical Terms:

201246
Cellular therapy.

LC Class. No.: RM301.37 / .C455 2019

Dewey Class. No.: 615.89

Cell and gene therapies
LDR:03464nmm a2200337 a 4500 001 552590
003 DE-He213
005 20190617172418.0
006 m d
007 cr nn 008maaau
008 191106s2019 gw s 0 eng d
020 $a 9783319543680$q(electronic bk.)
020 $a 9783319543673$q(paper)
024 7 $a 10.1007/978-3-319-54368-0 $2 doi
035 $a 978-3-319-54368-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.37 $b .C455 2019
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 615.89 $2 23
090 $a RM301.37 $b .C393 2019
245 0 0 $a Cell and gene therapies $h [electronic resource] / $c edited by Miguel-Angel Perales, Syed A. Abutalib, Catherine Bollard.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a vi, 288 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances and controversies in hematopoietic transplantation and cell therapy, $x 2569-1376
505 0 $a Historical perspective and current focus -- Part I: Genetically modified T cells (Chimeric antigen receptors and T cell receptors): Chimeric antigen receptor-T cells: Antigen selection, CAR development and future prospects -- Chimeric antigen receptor-T cells for leukemias in children: Methods, data and challenges -- Chimeric antigen receptor-T cells for leukemias in adults- Methods, data and challenges -- Chimeric antigen receptor-T cells for lymphomas: Methods, data and challenges -- T-cell receptors-gene modified T-cells for cancer -- Methods, data and challenges. -- Part II: Beyond chimeric antigen receptor and T-cell receptors - Data, Consensus & Challenges: Cytotoxic T cells for infections: From donor-specific to "off the shelf" -- Donor lymphocyte infusion in different transplant settings: When and how?- T-regulatory cells: Broadening applicability -- Tumor infiltrating lymphocytes: Current concepts and practices -- Part III: Beyond T-cells: Natural killer cells: What have we learned?- Dendritic cells in hematopoietic cell transplantation -- Mesenchymal stem cells: From bench to bedside and back -- Cell Therapies: Regulatory concerns and data collection -- Part IV: Gene Therapy: Gene therapy for hematologic malignancies and in transplant setting -- Gene therapy for nonmalignant disorders -- Future prospects of cell and gene therapies.
520 $a In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with information that is relevant to clinical practice and ongoing research. Each chapter focuses on a particular topic, and the concise text is supported by numerous working tables, algorithms, and figures. Whenever appropriate, guidance is provided regarding the availability of potentially high-impact clinical trials. The rapid evolution of cell and gene therapies is giving rise to numerous controversies that need to be carefully addressed. In meeting this challenge, this book will appeal to all residents, fellows, and faculty members responsible for the care of hematopoietic cell transplant patients. It will also offer a robust, engaging tool to aid vital activities in the daily work of every hematology and oncology trainee.
650 0 $a Cellular therapy. $3 201246
650 1 4 $a Hematology. $3 274899
650 2 4 $a Oncology. $3 195181
700 1 $a Perales, Miguel-Angel. $3 833382
700 1 $a Abutalib, Syed A. $3 758756
700 1 $a Bollard, Catherine. $3 833383
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances and controversies in hematopoietic transplantation and cell therapy. $3 787773
856 4 0 $u https://doi.org/10.1007/978-3-319-54368-0
950 $a Medicine (Springer-11650)